Touchlight
Generated by Meeveem AI
"Pioneering cell-free DNA manufacturing for faster, safer genetic medicine development"
Hampton
•51 - 250 Employees
•Contract Research
About Touchlight
Touchlight manufactures synthetic DNA using proprietary dbDNA™ technology, a cell-free enzymatic process that eliminates bacterial fermentation. This delivers high-purity DNA faster and at scale, supporting developers of mRNA therapies, viral vectors, gene editing tools, and DNA vaccines. The platform removes constraints like antibiotics and cell banking, enabling cleaner products and shorter timelines from research grade to GMP standards. Founded in 2007, Touchlight operates the world's first GMP licensed cell-free DNA facility in Hampton, UK. The company has produced over 1,500 batches and partners with Bayer, Pfizer, GSK, and Lonza to advance genetic medicine, addressing rising global demand for scalable DNA manufacturing.
190
Team Members
2007
Founded
Contract Research
Sector
On-Site
Work Environment
Our Vision
A world where genetic medicine reaches patients faster and more affordably, unconstrained by outdated manufacturing methods, enabling breakthrough therapies to transform human health globally.
Our Mission
Touchlight manufactures high-purity, cell-free DNA that accelerates the development of genetic medicines, removing the constraints of traditional fermentation to deliver safer, faster, and more scalable solutions for innovators worldwide.